Document is current
Any future updates will be listed below
-
Authors
Shek, Dmitrii
Gao, Bo
Lai, Joey
Yoon, Won-Hee
Moujaber, Tania
Nagrial, Adnan
Carlino, Matteo
Read, Scott
Ahlenstiel, Golo
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04631731 at ClinicalTrials.govnct04631731 at ClinicalTrials.govDocuments that mention this clinical trial
522 Transcriptomic changes in cancer patients treated with immune-checkpoint inhibitors
https://doi.org/10.1136/jitc-2021-sitc2021.522
177 Exploring the relationship between tumour heterogeneity and response to immunotherapy in malignant pleural mesothelioma
https://doi.org/10.1136/jitc-2023-sitc2023.0177
nct04631731 at ClinicalTrials.govDocuments that mention this clinical trial
522 Transcriptomic changes in cancer patients treated with immune-checkpoint inhibitors
https://doi.org/10.1136/jitc-2021-sitc2021.522
177 Exploring the relationship between tumour heterogeneity and response to immunotherapy in malignant pleural mesothelioma
https://doi.org/10.1136/jitc-2023-sitc2023.0177
Documents that mention this clinical trial
522 Transcriptomic changes in cancer patients treated with immune-checkpoint inhibitors
https://doi.org/10.1136/jitc-2021-sitc2021.522
177 Exploring the relationship between tumour heterogeneity and response to immunotherapy in malignant pleural mesothelioma
https://doi.org/10.1136/jitc-2023-sitc2023.0177
